Ravulizumab pharmacokinetics and pharmacodynamics in patients with generalized myasthenia gravis. Vu T, Ortiz S, Katsuno M, Annane D, et al. J Neurol 2023 Mar 9. doi: 10.1007/s00415-023-11617.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Vu T, Ortiz S, Katsuno M, Annane D, et al. Ravulizumab pharmacokinetics and pharmacodynamics in patients with generalized myasthenia gravis. J Neurol 2023 Mar 9. doi: 10.1007/s00415-023-11617.
PMID: 36890354